Home/Oncovita/Marc Grégoire
MG

Marc Grégoire

Collaborator (INSERM Unit 892, Nantes CHU)

Oncovita

Therapeutic Areas

Oncovita Pipeline

DrugIndicationPhase
MVdeltaCPleural MesotheliomaPre-clinical
Measovir®-based candidateBladder CancerPre-clinical
Measovir®-based Prophylactic Vaccine (with Unither)UndisclosedResearch/Pre-clinical